DK0690721T3 - Behandling af Mycobakterielle sygdomme ved indgivelse af baktericidt/permeabilitets-forøgende proteinprodukter - Google Patents

Behandling af Mycobakterielle sygdomme ved indgivelse af baktericidt/permeabilitets-forøgende proteinprodukter

Info

Publication number
DK0690721T3
DK0690721T3 DK94910876T DK94910876T DK0690721T3 DK 0690721 T3 DK0690721 T3 DK 0690721T3 DK 94910876 T DK94910876 T DK 94910876T DK 94910876 T DK94910876 T DK 94910876T DK 0690721 T3 DK0690721 T3 DK 0690721T3
Authority
DK
Denmark
Prior art keywords
bactericidal
permeability
administration
treatment
protein products
Prior art date
Application number
DK94910876T
Other languages
English (en)
Inventor
Lewis H Lambert Jr
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of DK0690721T3 publication Critical patent/DK0690721T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94910876T 1993-03-12 1994-03-11 Behandling af Mycobakterielle sygdomme ved indgivelse af baktericidt/permeabilitets-forøgende proteinprodukter DK0690721T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3114593A 1993-03-12 1993-03-12
PCT/US1994/002463 WO1994020129A1 (en) 1993-03-12 1994-03-11 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products

Publications (1)

Publication Number Publication Date
DK0690721T3 true DK0690721T3 (da) 1999-03-08

Family

ID=21857874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94910876T DK0690721T3 (da) 1993-03-12 1994-03-11 Behandling af Mycobakterielle sygdomme ved indgivelse af baktericidt/permeabilitets-forøgende proteinprodukter

Country Status (10)

Country Link
EP (1) EP0690721B1 (da)
AT (1) ATE165976T1 (da)
AU (1) AU6361894A (da)
CA (1) CA2157925C (da)
DE (1) DE69410254T2 (da)
DK (1) DK0690721T3 (da)
ES (1) ES2119185T3 (da)
GR (1) GR3027620T3 (da)
HK (1) HK1010983A1 (da)
WO (1) WO1994020129A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US6214789B1 (en) 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
AU7175694A (en) 1993-06-17 1995-01-17 Xoma Corporation Lipopolysaccharide binding protein derivatives
US5770561A (en) * 1993-07-14 1998-06-23 Xoma Corporation Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products
AU7330994A (en) * 1993-07-14 1995-02-13 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
PT759774E (pt) * 1993-09-22 2002-11-29 Xoma Technology Ltd Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
CN1133634A (zh) * 1993-09-22 1996-10-16 爱克斯欧玛公司 定量体液中的bpi的方法
US6759203B1 (en) 1993-09-22 2004-07-06 Xoma Corporation Method for quantifying BPI in body fluids
CA2181165C (en) * 1994-01-14 2007-06-05 Roger G. Ii Little Anti-fungal methods and materials
WO1995019180A1 (en) * 1994-01-14 1995-07-20 Xoma Corporation Anti-gram-positive bacterial methods and materials
US5447913A (en) 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US6271203B1 (en) 1994-07-07 2001-08-07 Xoma Corporation Anti-protozoan methods and materials
US5646114A (en) 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods
US5494896A (en) * 1995-03-31 1996-02-27 Xoma Corporation Method of treating conditions associated with burn injuries
AU727085B2 (en) * 1995-07-20 2000-11-30 Xoma Corporation Anti-fungal peptides
AU735058B2 (en) * 1996-05-10 2001-06-28 Xoma Corporation Therapeutic uses of BPI protein products for human meningococcemia
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
ATE234111T1 (de) * 1996-05-23 2003-03-15 Xoma Technology Ltd Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
ATE229812T1 (de) * 1996-11-01 2003-01-15 Xoma Technology Ltd Therapeutische verwendung von bpi proteineprodukten bei patienten mit zystischer fibrose
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
EP1741440A1 (en) 2005-07-08 2007-01-10 Mellitus S.L. Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
DE69128968T2 (de) * 1990-12-03 1998-10-08 Univ New York Biologisch aktive bakterizide/permeabilitätserhöhende proteinbruchstücke

Also Published As

Publication number Publication date
WO1994020129A1 (en) 1994-09-15
ES2119185T3 (es) 1998-10-01
CA2157925C (en) 2000-06-06
DE69410254D1 (de) 1998-06-18
DE69410254T2 (de) 1998-12-17
AU6361894A (en) 1994-09-26
EP0690721A1 (en) 1996-01-10
CA2157925A1 (en) 1994-09-15
EP0690721B1 (en) 1998-05-13
GR3027620T3 (en) 1998-11-30
HK1010983A1 (en) 1999-07-02
ATE165976T1 (de) 1998-05-15

Similar Documents

Publication Publication Date Title
DK0690721T3 (da) Behandling af Mycobakterielle sygdomme ved indgivelse af baktericidt/permeabilitets-forøgende proteinprodukter
CA2157927A1 (en) Therapeutic uses of bactericidal/permeability increasing protein produc ts
IL110031A0 (en) Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
AU1679795A (en) Anti-fungal methods and materials
DE69526120T2 (de) Verwendung von nebivolol als anti-atherogenisches mittel
AU3909497A (en) Anti-chlamydial methods and materials
DK0858504T3 (da) Diagnostiske midler mod og behandlinger af periodontale sygdomme
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE304371T1 (de) Verwendung von staphylococcus enterotoxin homologe für krebs-therapie
IL125441A0 (en) Novel diphenyl stilbenes and pharmaceutical compositions thereof for treatment of cox-2 mediated diseases
SE9303853L (sv) Användning av en inositoltrisfosfatester för beredning av läkemedel
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
ATE184287T1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
BR9813098A (pt) Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
PT930879E (pt) Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
UA29106A (uk) Спосіб лікування вібраційної хвороби